Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,031 | 804 | 96.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $392.63 | 1 | 3.1% |
| Education | $103.66 | 6 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,569 | 66 | $0 (2023) |
| Novo Nordisk Inc | $1,208 | 97 | $0 (2023) |
| AbbVie Inc. | $770.17 | 57 | $0 (2023) |
| Lilly USA, LLC | $754.68 | 64 | $0 (2023) |
| GlaxoSmithKline, LLC. | $742.68 | 26 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $519.15 | 37 | $0 (2023) |
| Amgen Inc. | $506.88 | 32 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $406.15 | 29 | $0 (2023) |
| Allergan, Inc. | $403.82 | 27 | $0 (2020) |
| PFIZER INC. | $373.22 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $1,889 | 121 | Lilly USA, LLC ($209.86) |
| 2022 | $2,006 | 127 | ABBVIE INC. ($230.03) |
| 2021 | $1,818 | 112 | AbbVie Inc. ($274.24) |
| 2020 | $1,898 | 97 | GlaxoSmithKline, LLC. ($433.87) |
| 2019 | $1,656 | 116 | AstraZeneca Pharmaceuticals LP ($261.79) |
| 2018 | $1,699 | 118 | AstraZeneca Pharmaceuticals LP ($342.32) |
| 2017 | $1,561 | 120 | AstraZeneca Pharmaceuticals LP ($172.32) |
All Payment Transactions
811 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: RESPIRATORY | ||||||
| 12/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 12/14/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $15.83 | General |
| 12/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Biological | ||||||
| 12/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/11/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.19 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: NEUROSCIENCE | ||||||
| 12/01/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/28/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Diabetes | ||||||
| 11/28/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Diabetes | ||||||
| 11/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Diabetes | ||||||
| 11/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardio-renal | ||||||
| 11/16/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2023 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Respiratory | ||||||
| 11/13/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2023 | Forte Bio-Pharma LLC | NALOCET (Drug), PROLATE, PROLATE | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: PAIN | ||||||
| 10/30/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Biological | ||||||
| 10/26/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $14.46 | General |
| 10/24/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: PSYCHIATRY | ||||||
| 10/13/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $19.84 | General |
| 10/13/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,601 | 2,282 | $342,650 | $127,384 |
| 2022 | 20 | 1,683 | 2,412 | $345,400 | $132,481 |
| 2021 | 18 | 1,628 | 2,400 | $335,753 | $127,406 |
| 2020 | 18 | 1,550 | 2,351 | $298,385 | $92,364 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 472 | 900 | $211,500 | $66,298 | 31.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 333 | 333 | $66,600 | $39,764 | 59.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 164 | 213 | $33,867 | $11,649 | 34.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $10,080 | $2,264 | 22.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 32 | 33 | $1,815 | $1,779 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 106 | 160 | $5,600 | $1,509 | 27.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 125 | 167 | $1,670 | $1,396 | 83.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 32 | $1,728 | $908.16 | 52.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 64 | 64 | $3,904 | $566.46 | 14.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 192 | 230 | $2,760 | $506.00 | 18.3% |
| 85610 | Blood test, clotting time | Office | 2023 | 11 | 78 | $1,638 | $327.60 | 20.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 12 | 12 | $1,008 | $222.03 | 22.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 31 | 32 | $480.00 | $195.52 | 40.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 446 | 838 | $196,930 | $64,382 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 267 | 267 | $53,400 | $32,270 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 167 | 231 | $36,729 | $12,156 | 33.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 54 | 54 | $10,800 | $8,415 | 77.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 13 | 13 | $5,785 | $3,617 | 62.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 24 | 24 | $8,640 | $2,270 | 26.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 30 | 31 | $1,705 | $1,672 | 98.1% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 97 | 148 | $5,180 | $1,419 | 27.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 35 | 35 | $1,890 | $954.45 | 50.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 157 | 223 | $2,230 | $657.99 | 29.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 69 | 69 | $4,209 | $628.74 | 14.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,978 | $600.89 | 15.1% |
About Dr. Jeffry Strohmyer, M.D
Dr. Jeffry Strohmyer, M.D is a Family Medicine healthcare provider based in Papillion, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275565939.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffry Strohmyer, M.D has received a total of $12,528 in payments from pharmaceutical and medical device companies, with $1,889 received in 2023. These payments were reported across 811 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($12,031).
As a Medicare-enrolled provider, Strohmyer has provided services to 6,462 Medicare beneficiaries, totaling 9,445 services with total Medicare billing of $479,634. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Papillion, NE
- Active Since 07/06/2006
- Last Updated 08/21/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275565939
Products in Payments
- FARXIGA (Drug) $590.78
- Ozempic (Drug) $514.82
- ENTRESTO (Drug) $406.15
- UBRELVY (Drug) $404.83
- HAVRIX (Biological) $392.63
- JARDIANCE (Drug) $373.05
- Kerendia (Drug) $357.69
- SYMBICORT (Drug) $331.36
- Livalo (Drug) $310.78
- Vascepa (Drug) $237.25
- Trintellix (Drug) $231.60
- BREZTRI (Drug) $230.81
- REXULTI (Drug) $220.17
- JANUVIA (Drug) $217.84
- NURTEC ODT (Drug) $213.72
- EMGALITY (Drug) $212.92
- Prolia (Biological) $200.95
- VRAYLAR (Drug) $200.54
- XARELTO (Drug) $192.16
- MOVANTIK (Drug) $191.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Papillion
Dr. Lorrie Mcgill, Md, MD
Family Medicine — Payments: $138,175
Sarah Hurd, M.d, M.D
Family Medicine — Payments: $8,818
Cindy Janssen, D.o, D.O
Family Medicine — Payments: $7,960
Katlin Nadrchal, Pa-C, PA-C
Family Medicine — Payments: $4,705
Adam Rasmussen, Md, MD
Family Medicine — Payments: $3,774
Paul Mueller, M.d, M.D
Family Medicine — Payments: $2,838